Trillions of dollars flow into Meta and OpenAI as they chase artificial super intelligence. Emilia Javorsky of the Future of Life Institute challenges the common narrative that these general-purpose models are necessary for medical breakthroughs. This critique suggests that specialized tools, rather than AGI, remain the practical path for solving complex biological problems.